Search Results 1541-1550 of 14663 for anti-TNF drugs

  1. Thalidomide (Oral Route) Description and Brand Names - Mayo Clinic

    This medicine is also used to treat moderate to severe new lesions of leprosy and as maintenance treatment to prevent and keep erythema nodosum leprosum (skin ...

  2. Tocilizumab (Intravenous Route, Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  3. Factor Xiii (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Corifact; Tretten. Descriptions. Factor ...

  4. Cefpodoxime (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) - Mayo Clinic

    ... treatment (including both insulin dependent and non-insulin dependent diabetes mellitus); Current or past use of insulin or any other anti-diabetic medication ...

  6. Hydralazine And Hydrochlorothiazide (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Apresazide. Descriptions. Hydralazine and hydrochlorothiazide ...

  7. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

    About this study. The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after ...

  8. Retrospective study finds that cancer drug also lowers blood glucose - Mayo Clinic News Network

    ROCHESTER, Minnesota — Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used ...

  9. Ado-Trastuzumab Emtansine (Intravenous Route) Description and Brand Names - Mayo Clinic

    It is also used as additional treatment in patients with HER2-positive early breast cancer who have cancer left after a taxane medicine and trastuzumab-based ...

  10. XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

    ... therapy; or arthritis that is managed without systemic therapy beyond oral acetaminophen and nonsteroidal anti-inflammatory drugs) * Have any condition ...